Clinical Trial Update: Exemestane in Advanced and Recurrent Endometrial Carcinoma [Phase 2]

View source ↗

Summary

This document notes the completion of a Phase 2 clinical trial evaluating exemestane for advanced and recurrent endometrial carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Exemestane (Exemestane)

Snippet

Sponsor: Nordic Society of Gynaecological Oncology - Clinical Trials Unit | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED